CDMO News
Rentschler Biopharma Ends Cell and Gene Therapy Work, Strengthens Biologics Focus
Rentschler Biopharma SE, a global CDMO, has announced a strategic shift, withdrawing from cell and gene therapy development and closing its Stevenage, UK facility. The move aligns with the company’s long-term growth strategy and response to evolving market conditions. The
31 January 2025
Stay ahead of trends and best practices
